Metrics as of 10/16/2026, 08:32 AM (Berlin time), refresh in progress.
Vyome Holdings Stock
Vyome Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Venkateswarlu Nelabhotla
- Employees
- 18
- Market cap
- $13 M
- IPO
- 06/10/2016
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United…
Vyome Holdings stock: price history
1D
-2.1%
1W
-10.5%
1M
-4.1%
6M
-15.4%
YTD
-45.6%
1Y
-63.0%
2Y
-99.6%
5Y
-100.0%
10Y
-100.0%
Next earnings date
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~86% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Vyome Holdings
Analyst assessment of Vyome Holdings
PRICE TARGET LOW
US$3.50
CONSENSUS
US$3.50
MEDIAN
US$3.50
PRICE TARGET HIGH
US$3.50
0
STRONG BUY
1
BUY
2
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Hold
As of: 17/07/2024
Vyome Holdings stock metrics
P/E
-0.06
P/B
2.17
EV/EBITDA
-0.46
RETURN ON EQUITY
-11.3%
NET MARGIN
-2,543.3%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
28.8%
FLOAT SHARES
2,018,183
AVG. DAILY VOLUME (30D)
17,641
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Vyome Holdings stock
What does Vyome Holdings do?
Vyome Holdings, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Venkateswarlu Nelabhotla, the company employs around 18 people.
The IPO was on 06/10/2016; the stock trades on NASDAQ under the ticker HIND.
What do analysts say about Vyome Holdings stock?
3 analysts rate the stock, the consensus is Hold (as of 17/07/2024).
The average price target is US$3.50, ranging from US$3.50 to US$3.50, with a median of US$3.50.
This is an external assessment, not a statement by Market Jury.
When does Vyome Holdings report next?
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly 86% stronger than usual.
Does Vyome Holdings pay a dividend?
No, Vyome Holdings currently does not pay a dividend.
Which stocks are comparable to Vyome Holdings?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Vyome Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Vyome Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.